AAAAAA

   
Results: 1-3 |
Results: 3
QUANTITATIVE-ANALYSIS OF SYNCYTIUM-INDUCING AND NON-SYNCYTIUM-INDUCING VIRUS IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
Authors: SHAFER RW AGUINIGA E MERIGAN TC
Citation: Rw. Shafer et al., QUANTITATIVE-ANALYSIS OF SYNCYTIUM-INDUCING AND NON-SYNCYTIUM-INDUCING VIRUS IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, Journal of clinical microbiology, 33(1), 1995, pp. 212-214
DRUG-RESISTANCE AND HETEROGENEOUS LONG-TERM VIROLOGICAL RESPONSES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED SUBJECTS TO ZIDOVUDINE AND DIDANOSINE COMBINATION THERAPY
Authors: SHAFER RW IVERSEN AKN WINTERS MA AGUINIGA E KATZENSTEIN DA MERIGAN TC
Citation: Rw. Shafer et al., DRUG-RESISTANCE AND HETEROGENEOUS LONG-TERM VIROLOGICAL RESPONSES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED SUBJECTS TO ZIDOVUDINE AND DIDANOSINE COMBINATION THERAPY, The Journal of infectious diseases, 172(1), 1995, pp. 70-78
HIV-1 SYNCYTIUM-INDUCING PHENOTYPE, VIRUS BURDEN CODON-215 REVERSE-TRANSCRIPTASE MUTATION AND CD4 CELL DECLINE IN ZIDOVUDINE-TREATED PATIENTS
Authors: KOZAL MJ SHAFER RW WINTERS MA KATZENSTEIN DA AGUINIGA E HALPERN J MERIGAN TC
Citation: Mj. Kozal et al., HIV-1 SYNCYTIUM-INDUCING PHENOTYPE, VIRUS BURDEN CODON-215 REVERSE-TRANSCRIPTASE MUTATION AND CD4 CELL DECLINE IN ZIDOVUDINE-TREATED PATIENTS, Journal of acquired immune deficiency syndromes, 7(8), 1994, pp. 832-838
Risultati: 1-3 |